Press release - 12/05/2026 The Silent Killer: Early Detection and Targeted Treatment of High Blood Pressure High blood pressure is one of the most common causes of heart attacks, strokes, kidney damage, and vascular diseases. Many people affected experience no symptoms for a long time. This is precisely why it is important to check your blood pressure regularly. To mark World Hypertension Day on May 17, the Medical Center – University of Freiburg is providing information on warning signs, diagnosis, and treatment options.https://www.gesundheitsindustrie-bw.de/en/article/press-release/silent-killer-early-detection-and-targeted-treatment-high-blood-pressure
Press release - 11/05/2026 Radar warns of a risk of falling at the hospital The Medical Center – University of Freiburg has implemented a new system that helps nurses identify risky situations early on and provide more targeted assistance / Motion detection is performed using radarhttps://www.gesundheitsindustrie-bw.de/en/article/press-release/radar-warns-risk-falling-hospital
Press release - 13/05/2026 NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies NVision announced a $55 million Series B led by Abbott and unveiled PIQC, a new quantum computing platform built on its molecular quantum technology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nvision-expands-quantum-sensing-quantum-computing-accelerate-discovery-and-validation-new-therapies-en
Press release - 18/05/2026 Gene scissors show promise for treating a rare immune disorder Medical Center – University of Freiburg demonstrates a fundamental therapeutic approach for hereditary immune system defects in a mouse model. The safety profile of genome editing varies significantly depending on the method and cell type.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-scissors-show-promise-treating-rare-immune-disorder
Press release - 15/05/2026 Heidelberg Collaborative Research Centre “Molecular Circuits of Heart Disease” secures second funding period The Collaborative Research Centre (CRC) 1550 “Molecular Circuits of Heart Disease” at Heidelberg University is entering its second funding period. The German Research Foundation (DFG) has approved approximately EUR 17.4 million in funding for the next four years. The spokesperson is Johannes Backs, Professor of Experimental Cardiology at the Heidelberg Faculty of Medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-collaborative-research-centre-molecular-circuits-heart-disease-secures-second-funding-period
Funding Funke Quantum-Driven Intelligence Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantum-driven-intelligence
Funding Funke QuantumSense Exploration Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantumsense-exploration
Event - 17/09/2026 - 18/09/2026 Translational Protein Biomarker Workshop Reutlingen, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/translational-protein-biomarker-workshop
Press release - 15/05/2026 Neuroendocrine Tumors: Freiburg Becomes a European Center of Excellence The Medical Center – University of Freiburg has been certified for the first time as a “Center of Excellence” by the European Neuroendocrine Tumor Society (ENETS). The professional association recognizes specialized centers that treat rare tumor diseases in accordance with established quality standards. Neuroendocrine tumors are rare cancers that can arise from hormone-producing cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/neuroendocrine-tumors-freiburg-becomes-european-center-excellence
Funding Continuous Hormone Monitoring Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 26/06/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/continuous-hormone-monitoring
Press release - 18/05/2026 Unlocking the Lung’s Ability to Heal: NK Cell Immunotherapy offers New Hope for Fibrosis Research jointly led by scientists at the Heidelberg site of the German Center for Lung Research and investigators in Boston at Massachusetts General Hospital and Harvard Medical School identifies a new immunotherapy-based approach for lung fibrosis: reactivating natural killer cell (NK cells) to eliminate senescent fibroblasts, reverse scarring and restore the lung’s ability to heal.https://www.gesundheitsindustrie-bw.de/en/article/press-release/unlocking-lungs-ability-heal-nk-cell-immunotherapy-offers-new-hope-fibrosis